182 related articles for article (PubMed ID: 7583006)
1. Vascular cell adhesion molecule (VCAM)-Ig fusion protein defines distinct affinity states of the very late antigen-4 (VLA-4) receptor.
Jakubowski A; Rosa MD; Bixler S; Lobb R; Burkly LC
Cell Adhes Commun; 1995 May; 3(2):131-42. PubMed ID: 7583006
[TBL] [Abstract][Full Text] [Related]
2. Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis.
Weber C; Alon R; Moser B; Springer TA
J Cell Biol; 1996 Aug; 134(4):1063-73. PubMed ID: 8769427
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium.
Vonderheide RH; Springer TA
J Exp Med; 1992 Jun; 175(6):1433-42. PubMed ID: 1375259
[TBL] [Abstract][Full Text] [Related]
4. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1.
Masumoto A; Hemler ME
J Biol Chem; 1993 Jan; 268(1):228-34. PubMed ID: 7677996
[TBL] [Abstract][Full Text] [Related]
5. Activation dependent and independent VLA-4 binding sites on vascular cell adhesion molecule-1.
Needham LA; Van Dijk S; Pigott R; Edwards RM; Shepherd M; Hemingway I; Jack L; Clements JM
Cell Adhes Commun; 1994 Jun; 2(2):87-99. PubMed ID: 7521763
[TBL] [Abstract][Full Text] [Related]
6. A high affinity conformational state on VLA integrin heterodimers induced by an anti-beta 1 chain monoclonal antibody.
Arroyo AG; García-Pardo A; Sánchez-Madrid F
J Biol Chem; 1993 May; 268(13):9863-8. PubMed ID: 8486666
[TBL] [Abstract][Full Text] [Related]
7. High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow.
Chen C; Mobley JL; Dwir O; Shimron F; Grabovsky V; Lobb RR; Shimizu Y; Alon R
J Immunol; 1999 Jan; 162(2):1084-95. PubMed ID: 9916737
[TBL] [Abstract][Full Text] [Related]
8. Alpha 4 beta 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand.
Yednock TA; Cannon C; Vandevert C; Goldbach EG; Shaw G; Ellis DK; Liaw C; Fritz LC; Tanner LI
J Biol Chem; 1995 Dec; 270(48):28740-50. PubMed ID: 7499396
[TBL] [Abstract][Full Text] [Related]
9. Post-receptor occupancy events in leukocytes during beta 1 integrin-ligand interactions.
Sánchez-Mateos P; Arroyo AG; Balboa MA; Sánchez-Madrid F
Eur J Immunol; 1993 Oct; 23(10):2642-8. PubMed ID: 7691611
[TBL] [Abstract][Full Text] [Related]
10. VLA-4 (alpha(4)beta(1)) engagement defines a novel activation pathway for beta(2) integrin-dependent leukocyte adhesion involving the urokinase receptor.
May AE; Neumann FJ; Schömig A; Preissner KT
Blood; 2000 Jul; 96(2):506-13. PubMed ID: 10887112
[TBL] [Abstract][Full Text] [Related]
11. Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes.
Damle NK; Aruffo A
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6403-7. PubMed ID: 1713678
[TBL] [Abstract][Full Text] [Related]
12. Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4: distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin.
Masumoto A; Hemler ME
J Cell Biol; 1993 Oct; 123(1):245-53. PubMed ID: 7691827
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody to beta 1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components.
Kovach NL; Carlos TM; Yee E; Harlan JM
J Cell Biol; 1992 Jan; 116(2):499-509. PubMed ID: 1370496
[TBL] [Abstract][Full Text] [Related]
14. Vascular cell adhesion molecule-Ig fusion protein selectively targets activated alpha 4-integrin receptors in vivo. Inhibition of autoimmune diabetes in an adoptive transfer model in nonobese diabetic mice.
Jakubowski A; Ehrenfels BN; Pepinsky RB; Burkly LC
J Immunol; 1995 Jul; 155(2):938-46. PubMed ID: 7608569
[TBL] [Abstract][Full Text] [Related]
15. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.
Elices MJ; Osborn L; Takada Y; Crouse C; Luhowskyj S; Hemler ME; Lobb RR
Cell; 1990 Feb; 60(4):577-84. PubMed ID: 1689216
[TBL] [Abstract][Full Text] [Related]
16. A region of the integrin VLA alpha 4 subunit involved in homotypic cell aggregation and in fibronectin but not vascular cell adhesion molecule-1 binding.
Muñoz M; Serrador J; Sánchez-Madrid F; Teixidó J
J Biol Chem; 1996 Feb; 271(5):2696-702. PubMed ID: 8576243
[TBL] [Abstract][Full Text] [Related]
17. ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands.
Campanero MR; Sánchez-Mateos P; del Pozo MA; Sánchez-Madrid F
J Cell Biol; 1994 Nov; 127(3):867-78. PubMed ID: 7525599
[TBL] [Abstract][Full Text] [Related]
18. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
[TBL] [Abstract][Full Text] [Related]
19. Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes.
Morales-Ducret J; Wayner E; Elices MJ; Alvaro-Gracia JM; Zvaifler NJ; Firestein GS
J Immunol; 1992 Aug; 149(4):1424-31. PubMed ID: 1380043
[TBL] [Abstract][Full Text] [Related]
20. Effect of divalent cations on the affinity and selectivity of alpha4 integrins towards the integrin ligands vascular cell adhesion molecule-1 and mucosal addressin cell adhesion molecule-1: Ca2+ activation of integrin alpha4beta1 confers a distinct ligand specificity.
Day ES; Osborn L; Whitty A
Cell Commun Adhes; 2002; 9(4):205-19. PubMed ID: 12699089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
